CDC grants for new infection strategies
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Disease Control and Prevention is soliciting grant proposals focusing, in part, on device and diagnostic interventions that would reduce hospital acquired infections in intensive care patients, central-line bloodstream infections, and the incidence of invasive methicillin-resistant staphylococcus aureus infections. CDC will award four grants worth up to $2 million each through its Prevention Epicenters Program, with a Sept. 30 deadline to apply. Catheter and catheter connector use, design and maintenance are among CDC's proposed areas of focus. At least one possible project would explore the effectiveness of various cleansing agents and techniques in reducing microbial contamination in catheter connectors and central venous catheters
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.